T1	CHEM 71 79	APIXABÁN
#1	AnnotatorNotes T1	C1831808; apixaban; Organic Chemical · Pharmacologic Substance
T2	PROC 96 113	HEMODIAFILTRACIÓN
#2	AnnotatorNotes T2	C0206075; Hemodiafiltration; Therapeutic or Preventive Procedure
T3	CHEM 183 191	APIXABÁN
#3	AnnotatorNotes T3	C1831808; apixaban; Organic Chemical · Pharmacologic Substance
T4	PROC 208 225	HEMODIAFILTRACIÓN
#4	AnnotatorNotes T4	C0206075; Hemodiafiltration; Therapeutic or Preventive Procedure
T5	DISO 249 273	Enfermedad renal crónica
#5	AnnotatorNotes T5	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T6	DISO 275 296	fibrilación auricular
#6	AnnotatorNotes T6	C0004238; Atrial Fibrillation; Disease or Syndrome
T7	ANAT 300 308	valvular
#7	AnnotatorNotes T7	C1186983; anatomic valve; Body Part, Organ, or Organ Component
T8	PROC 387 398	Diagnóstico
#8	AnnotatorNotes T8	C0011900; Diagnosis; Diagnostic Procedure
T9	DISO 402 426	enfermedad renal crónica
#9	AnnotatorNotes T9	C0403447; Chronic Kidney Insufficiency; Disease or Syndrome | C1561643; Chronic Kidney Diseases; Disease or Syndrome
T10	PROC 430 442	hemodiálisis
#10	AnnotatorNotes T10	C0019004; Hemodialysis; Therapeutic or Preventive Procedure
T11	PROC 472 483	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 514 535	fibrilación auricular
#12	AnnotatorNotes T12	C0004238; Atrial Fibrillation; Disease or Syndrome
T13	ANAT 539 547	valvular
#13	AnnotatorNotes T13	C1186983; anatomic valve; Body Part, Organ, or Organ Component
T14	PROC 551 562	tratamiento
#14	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	PROC 612 638	tratamiento anticoagulante
#15	AnnotatorNotes T15	C0150457; Anticoagulant therapy; Therapeutic or Preventive Procedure
T16	DISO 789 800	hepatopatía
#16	AnnotatorNotes T16	C0023895; Liver diseases; Disease or Syndrome
T17	CHEM 836 842	enzima
#17	AnnotatorNotes T17	C0014442; Enzymes; Amino Acid, Peptide, or Protein · Enzyme
T18	ANAT 843 852	hepáticos
#18	AnnotatorNotes T18	C0023884; Liver; Body Part, Organ, or Organ Component | C1278929; Entire liver; Body Part, Organ, or Organ Component
T19	PROC 857 860	AST
#19	AnnotatorNotes T19	C0201899; Aspartate aminotransferase measurement; Laboratory Procedure
T20	PROC 904 921	Bilirrubina total
#20	AnnotatorNotes T20	C0201913; Bilirubin, total measurement; Laboratory Procedure
T21	DISO 935 946	Trombopenia
#21	AnnotatorNotes T21	C0040034; Thrombocytopenia; Disease or Syndrome
T22	ANAT 957 966	plaquetas
#22	AnnotatorNotes T22	C0005821; Blood Platelets; Cell
T23	PROC 983 994	tratamiento
#23	AnnotatorNotes T23	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T24	CHEM 1022 1031	heparinas
#24	AnnotatorNotes T24	C0019134; heparin; Biologically Active Substance · Organic Chemical · Pharmacologic Substance
T25	CHEM 1035 1071	fármacos antiagregantes plaquetarios
T26	CHEM 1266 1275	fenitoina
#25	AnnotatorNotes T26	C0031507; phenytoin; Organic Chemical · Pharmacologic Substance
T27	PROC 1084 1095	tratamiento
#26	AnnotatorNotes T27	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T28	CHEM 1100 1123	inhibidores enzimáticos
#27	AnnotatorNotes T28	C0014432; Enzyme Inhibitors; Pharmacologic Substance | C0919438; Enzyme Inhibitor Drugs; Pharmacologic Substance
T29	CHEM 1130 1152	antimicóticos azolicos
T30	CHEM 1155 1189	inhibidores de la proteasa del HIV
#28	AnnotatorNotes T30	C3536912; Human Immunodeficiency Virus Protease Inhibitor; Pharmacologic Substance
T31	CHEM 1193 1215;1277 1299	inductores enzimáticos del citocromo P450 3A4
T32	CHEM 1222 1233	rifampicina
#29	AnnotatorNotes T32	C0035608; rifampin; Antibiotic · Organic Chemical
T33	CHEM 1235 1247	fenobarbital
#30	AnnotatorNotes T33	C0031412; phenobarbital; Organic Chemical · Pharmacologic Substance
T34	CHEM 1249 1262	carbamazepina
#31	AnnotatorNotes T34	C0006949; carbamazepine; Organic Chemical · Pharmacologic Substance
T36	DISO 1331 1339	sangrado
#33	AnnotatorNotes T36	C0019080; Hemorrhage; Pathologic Function
T37	DISO 1373 1407	alteraciones clínicas o analíticas
T38	DISO 1437 1453	enfermedad renal
#34	AnnotatorNotes T38	C0022658; Kidney Diseases; Disease or Syndrome
T39	PROC 1480 1494	ensayo clínico
#35	AnnotatorNotes T39	C0008976; Clinical Trials; Research Activity
T40	PROC 1498 1523	tratamiento farmacológico
#36	AnnotatorNotes T40	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T41	PROC 662 686	consentimiento informado
#37	AnnotatorNotes T41	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T42	ANAT 260 265	renal
#38	AnnotatorNotes T42	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T43	ANAT 287 296	auricular
#39	AnnotatorNotes T43	C0018792; Heart Atrium; Body Part, Organ, or Organ Component | C1280619; Entire atrium; Body Part, Organ, or Organ Component
T44	ANAT 368 376	corporal
#40	AnnotatorNotes T44	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T45	ANAT 413 418	renal
#41	AnnotatorNotes T45	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T46	ANAT 526 535	auricular
#42	AnnotatorNotes T46	C0018792; Heart Atrium; Body Part, Organ, or Organ Component | C1280619; Entire atrium; Body Part, Organ, or Organ Component
T47	CHEM 567 578	cumarínicos
#43	AnnotatorNotes T47	C0010206; coumarin; Organic Chemical · Pharmacologic Substance
T48	CHEM 624 638	anticoagulante
#44	AnnotatorNotes T48	C0003280; Anticoagulants; Pharmacologic Substance
T49	ANAT 757 765	corporal
#45	AnnotatorNotes T49	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T50	PROC 853 856	ALT
#46	AnnotatorNotes T50	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T51	CHEM 904 915	Bilirrubina
#47	AnnotatorNotes T51	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T52	CHEM 1005 1020	anticoagulantes
#48	AnnotatorNotes T52	C0003280; Anticoagulants; Pharmacologic Substance
T53	ANAT 1059 1071	plaquetarios
#49	AnnotatorNotes T53	C0005821; Blood Platelets; Cell
T54	ANAT 1448 1453	renal
#50	AnnotatorNotes T54	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T55	Date 13 17	2019
T56	LIVB 83 92	PACIENTES
#51	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T57	PHYS 136 151	FARMACOCINÉTICA
#52	AnnotatorNotes T57	C0031327; Drug Kinetics; Physiologic Function
T58	LIVB 195 204	PACIENTES
#53	AnnotatorNotes T58	C0030705; Patients; Patient or Disabled Group
T59	Duration 266 273	crónica
#54	AnnotatorNotes T59	C0205191; chronic; Temporal Concept
T60	Neg_cue 297 299	no
T61	LIVB 337 344	Adultos
#55	AnnotatorNotes T61	C0001675; Adult; Age Group
T62	Age 346 359	18 años o más
T63	Duration 419 426	crónica
#56	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	Duration 448 468	un mínimo de 3 meses
T65	Neg_cue 536 538	no
T66	LIVB 581 589	Paciente
#57	AnnotatorNotes T66	C0030705; Patients; Patient or Disabled Group
T67	LIVB 645 651	sujeto
#58	AnnotatorNotes T67	C0681850; Study Subject; Group
T68	LIVB 717 736	Mujeres embarazadas
#59	AnnotatorNotes T68	C0033011; Pregnant Women; Population Group
T69	LIVB 739 748	lactantes
#60	AnnotatorNotes T69	C4316174; Patients who are breastfeeding; Patient or Disabled Group
T70	LIVB 802 811	pacientes
#61	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	LIVB 1186 1189	HIV
#62	AnnotatorNotes T71	C0019682; HIV; Virus
T72	Date 1343 1356	el último mes
T74	PHYS 153 167	FARMACODINAMIA
#63	AnnotatorNotes T74	C0851347; Pharmacodynamics; Biologic Function
T75	PHYS 725 736	embarazadas
#64	AnnotatorNotes T75	C0032961; Pregnancy; Organism Function
T73	DISO 816 852	valores elevados de enzima hepáticos
#65	AnnotatorNotes T73	C5385310; Elevation of levels of alanine transaminase (ALT); Finding [ICD-10: R74.01] + C5385311; Elevation of levels of aspartate transaminase (AST); Finding [ICD-10: R74.01]
T76	PROC 363 376	Peso corporal
#66	AnnotatorNotes T76	C2985231; Body Weight Measurement; Diagnostic Procedure
T77	PROC 752 765	Peso corporal
#67	AnnotatorNotes T77	C2985231; Body Weight Measurement; Diagnostic Procedure
A1	Assertion T7 Negated
A2	Assertion T13 Negated
A3	Population_data T61 Age
A4	Status T36 History_of
#68	AnnotatorNotes T29	C0360363; Azole antifungal; Organic Chemical · Pharmacologic Substance 
T78	Neg_cue 1408 1410	no
T79	Quantifier_or_Qualifier 1411 1422	atribuibles
A5	Assertion T79 Negated
T80	Observation 486 507	estables clínicamente
#69	AnnotatorNotes T80	C1282982; Patient's condition stable; Finding
R1	Experiences Arg1:T56 Arg2:T1	
R2	Experiences Arg1:T56 Arg2:T2	
R3	Experiences Arg1:T58 Arg2:T57	
R4	Experiences Arg1:T58 Arg2:T74	
R5	Experiences Arg1:T58 Arg2:T3	
R6	Experiences Arg1:T58 Arg2:T4	
R9	Location_of Arg1:T42 Arg2:T5	
R10	Has_Duration_or_Interval Arg1:T5 Arg2:T59	
R11	Location_of Arg1:T43 Arg2:T6	
R12	Negation Arg1:T60 Arg2:T7	
R13	Location_of Arg1:T7 Arg2:T6	
R14	Has_Age Arg1:T61 Arg2:T62	
T81	Result_or_Value 377 383	≥ 60kg
R15	Location_of Arg1:T44 Arg2:T76	
R16	Has_Result_or_Value Arg1:T76 Arg2:T81	
R17	Location_of Arg1:T45 Arg2:T9	
R18	Has_Duration_or_Interval Arg1:T9 Arg2:T63	
R19	Used_for Arg1:T48 Arg2:T15	
R20	Has_Duration_or_Interval Arg1:T11 Arg2:T64	
R21	Has_Duration_or_Interval Arg1:T10 Arg2:T64	
R22	Overlap Arg1:T9 Arg2:T80	
R23	Overlap Arg1:T9 Arg2:T12	
R24	Overlap Arg1:T5 Arg2:T6	
R25	Location_of Arg1:T46 Arg2:T12	
R26	Location_of Arg1:T13 Arg2:T12	
R27	Negation Arg1:T65 Arg2:T13	
R28	Used_for Arg1:T47 Arg2:T14	
R29	Overlap Arg1:T80 Arg2:T12	
R30	Experiences Arg1:T66 Arg2:T15	
R31	Experiences Arg1:T68 Arg2:T75	
R32	Location_of Arg1:T49 Arg2:T77	
T82	Result_or_Value 766 772	≤ 60kg
R33	Has_Result_or_Value Arg1:T77 Arg2:T82	
R34	Experiences Arg1:T70 Arg2:T16	
R35	Location_of Arg1:T18 Arg2:T73	
R36	Experiences Arg1:T70 Arg2:T73	
R37	Experiences Arg1:T70 Arg2:T50	
R38	Experiences Arg1:T70 Arg2:T19	
T83	Result_or_Value 922 930	>1.5 LSN
R41	Has_Result_or_Value Arg1:T20 Arg2:T83	
T84	Result_or_Value 861 900	>2x el límite superior de la normalidad
R42	Has_Result_or_Value Arg1:T19 Arg2:T84	
R43	Has_Result_or_Value Arg1:T50 Arg2:T84	
R48	Experiences Arg1:T70 Arg2:T20	
T85	Result_or_Value 948 969	<100.000 plaquetas/mL
R49	Has_Result_or_Value Arg1:T21 Arg2:T85	
R50	Used_for Arg1:T52 Arg2:T23	
R51	Used_for Arg1:T24 Arg2:T23	
R52	Used_for Arg1:T25 Arg2:T23	
#70	AnnotatorNotes T25	C0032177; Platelet Aggregation Inhibitors; Pharmacologic Substance
R53	Used_for Arg1:T28 Arg2:T27	
R54	Used_for Arg1:T29 Arg2:T27	
R55	Used_for Arg1:T30 Arg2:T27	
R56	Used_for Arg1:T32 Arg2:T27	
R57	Used_for Arg1:T33 Arg2:T27	
R58	Used_for Arg1:T34 Arg2:T27	
R59	Used_for Arg1:T26 Arg2:T27	
#71	AnnotatorNotes T31	C3850041; Cytochrome P-450 CYP3A4 Inducers; Pharmacologic Substance
R60	Overlap Arg1:T36 Arg2:T72	
R61	Negation Arg1:T78 Arg2:T79	
#72	AnnotatorNotes T79	C0015127; Etiology aspects; Functional Concept | C1314792; Etiology; Functional Concept 
R62	Has_Quantifier_or_Qualifier Arg1:T37 Arg2:T79	
R63	Overlap Arg1:T37 Arg2:T38	
R64	Location_of Arg1:T54 Arg2:T38	
R67	Overlap Arg1:T11 Arg2:T14	
R68	Overlap Arg1:T10 Arg2:T14	
T86	Observation 1458 1494	Participación en otro ensayo clínico
R7	Used_for Arg1:T31 Arg2:T27	
A6	Experiencer T66 Patient
A7	Experiencer T67 Patient
A8	Experiencer T69 Patient
A9	Experiencer T68 Patient
A10	Experiencer T56 Patient
A11	Experiencer T58 Patient
A12	Experiencer T61 Patient
A13	Experiencer T70 Patient
A14	Status T15 Future
